je.st
news
Biogen Idec and Sobi Present New Data from the Phase 3 Study of Their ...
2013-07-04 18:03:24| Biotech - Topix.net
Biogen Idec and Swedish Orphan Biovitrum AB presented new data that support the clinical and safety profile of their long-lasting recombinant factor VIII candidate ELOCTATE* for hemophilia A. Five platform and oral presentations at the XXIV International Society on Thrombosis and Haemostasis Congress in Amsterdam, The Netherlands, highlight the ... (more)
Tags: of
their
data
present
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||